AJCP CME: Loss of SATB2 in colorectal cancer is associated with inferior survival and adverse clinicopathological features: a meta-analysis

This AJCP article offers 1.0 continuing education (CME) credit that can be used to fulfill CC Part II requirements. The article has been published open access and is freely accessible here.

Write a Review

List Price: $25.00
Member Price: $19.00

Quantity:

Want to save more?

Log into see if you qualify for a lower rate.

Members

save $6.00 or more

Join

Item Details:

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, learners will be able to:

Summarize key aspects of SATB2: its expression and distribution in normal tissues, its biological role, and effects of SATB2 absence on congenital...

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, learners will be able to:

Summarize key aspects of SATB2: its expression and distribution in normal tissues, its biological role, and effects of SATB2 absence on congenital abnormalities and developmental disorders.
Describe the impact of SATB2 expression or loss in colonic adenocarcinomas on survival, staging, and disease-free survival.
List mutations and histological features seen in colonic adenocarcinomas that have lost expression of SATB2.

View More View Less